Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMM: Bortezomib, Cyclophosphamide, and Dexamethasone in Multiple Myeloma
NCT02467010Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2008
- Primary completion
- Jul 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by University Medical Center Groningen. Started Sep 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02467010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467010.